193 related articles for article (PubMed ID: 12637123)
1. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations.
Weidmann E; Unger J; Blair S; Friesen C; Hart C; Cady R
Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of sumatriptan tablets in migraineurs self-described or physician-diagnosed as having sinus headache: a randomized, double-blind, placebo-controlled study.
Ishkanian G; Blumenthal H; Webster CJ; Richardson MS; Ames M
Clin Ther; 2007 Jan; 29(1):99-109. PubMed ID: 17379050
[TBL] [Abstract][Full Text] [Related]
3. Oral almotriptan vs. oral sumatriptan in the abortive treatment of migraine: a double-blind, randomized, parallel-group, optimum-dose comparison.
Spierings EL; Gomez-Mancilla B; Grosz DE; Rowland CR; Whaley FS; Jirgens KJ
Arch Neurol; 2001 Jun; 58(6):944-50. PubMed ID: 11405809
[TBL] [Abstract][Full Text] [Related]
4. Clinical applications of new therapeutic deliveries in migraine.
Dahlöf C
Neurology; 2003 Oct; 61(8 Suppl 4):S31-4. PubMed ID: 14581656
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
6. Long-term tolerability of sumatriptan nasal spray in adolescent patients with migraine.
Natarajan S; Jabbour JT; Webster CJ; Richardson MS
Headache; 2004; 44(10):969-77. PubMed ID: 15546259
[TBL] [Abstract][Full Text] [Related]
7. How does sumatriptan nasal spray perform in clinical practice?
Dahlöf CG; Boes-Hansen S; Cederberg CG; Hardebo JE; Henriksson A
Cephalalgia; 1998 Jun; 18(5):278-82. PubMed ID: 9673808
[TBL] [Abstract][Full Text] [Related]
8. [Sumatriptan nasal spray 20mg: efficacy, tolerance and quality of life in migraine patients].
Géraud G; Valette C
Rev Neurol (Paris); 2000 Jul; 156(6-7):646-53. PubMed ID: 10891800
[TBL] [Abstract][Full Text] [Related]
9. Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered
Silberstein S; Winner PK; McAllister PJ; Tepper SJ; Halker R; Mahmoud RA; Siffert J
Headache; 2017 Jun; 57(6):862-876. PubMed ID: 28497569
[TBL] [Abstract][Full Text] [Related]
10. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
Dodick D; Brandes J; Elkind A; Mathew N; Rodichok L
CNS Drugs; 2005; 19(2):125-36. PubMed ID: 15697326
[TBL] [Abstract][Full Text] [Related]
11. Parental satisfaction with sumatriptan nasal spray in childhood migraine.
Pakalnis A; Kring D; Paolicchi J
J Child Neurol; 2003 Nov; 18(11):772-5. PubMed ID: 14696905
[TBL] [Abstract][Full Text] [Related]
12. One-year tolerability and efficacy of sumatriptan nasal spray in adolescents with migraine: results of a multicenter, open-label study.
Rothner AD; Winner P; Nett R; Asgharnejad M; Laurenza A; Austin R; Peykamian M
Clin Ther; 2000 Dec; 22(12):1533-46. PubMed ID: 11192144
[TBL] [Abstract][Full Text] [Related]
13. Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Loder E; Brandes JL; Silberstein S; Skobieranda F; Bohidar N; Wang L; Boyle D; Kolodny A; Guerra F; Santanello N; Johnson-Pratt L;
Headache; 2001 Sep; 41(8):745-53. PubMed ID: 11576197
[TBL] [Abstract][Full Text] [Related]
14. Mixing sumatriptan: a prospective study of stratified care using multiple formulations.
Kaniecki RG
Headache; 2001 Oct; 41(9):862-6. PubMed ID: 11703472
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tablets.
Savani N; Pfaffenrath V; Rice L; Boswell D; Black L; Jones M;
Clin Ther; 2001 Feb; 23(2):260-71. PubMed ID: 11293559
[TBL] [Abstract][Full Text] [Related]
16. Pain-free efficacy after treatment with sumatriptan in the mild pain phase of menstrually associated migraine.
Nett R; Landy S; Shackelford S; Richardson MS; Ames M; Lener M
Obstet Gynecol; 2003 Oct; 102(4):835-42. PubMed ID: 14551015
[TBL] [Abstract][Full Text] [Related]
17. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan.
Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E
Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and satisfaction with zolmitriptan 5 mg nasal spray for treatment of migraine in real-life practice: results of a postmarketing surveillance study.
Diener HC; Evers S
Clin Drug Investig; 2007; 27(1):59-66. PubMed ID: 17177580
[TBL] [Abstract][Full Text] [Related]
19. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study.
Carpay HA; Matthijsse P; Steinbuch M; Mulder PG
Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
